Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-01-30

FDA Approved: JENTADUETO — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved JENTADUETO (linagliptin and metformin hydrochloride) under an Original Application by Boehringer Ingelheim Pharmaceuticals, Inc. This approval is f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jentadueto (linagliptin/metformin)

Snippet

ORIG AP for JENTADUETO (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE)